FIELD: medicine.
SUBSTANCE: blood serum is sampled from individuals presumably infected with such virus for the first time in 3-4 hours and for the second time - in 15-18 hours after presumed infection. Each serum sample is examined for a level of hemolytic complement activity (HCA) by any known technique. If observing the HCA in 1.5-2.0 times and more for a specified period of time, the fact of body infection is stated, and the absence or minor change of the HCA shows the absence of body infection. The HCA level can be evaluated by unified technique showing intact sheep erythrocyte lysis with commercial hemolytic anti-sheep rabbit serum.
EFFECT: use of the technique enables earlier diagnosing of Ebola hemorrhagic fever that will allow prescribing a complete complex of therapeutic actions immediately.
2 cl, 1 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF INHIBITING INFECTIOUS ACTIVITY OF EBOLA VIRUS IN EXPERIMENT | 2015 |
|
RU2585695C1 |
| EBOLA-ZAIRE VIRUS STRAIN ESMS 2020 ADAPTED FOR GUINEA PIGS, INTENDED FOR PRECLINICAL TESTING OF MEDICAL PROTECTIVE MEANS AGAINST EBOLA HEMORRHAGIC FEVER | 2020 |
|
RU2749345C1 |
| SINGLE-DOMAIN ANTIBODIES TO EBOLA VIRUS GP PROTEIN FOR IMMUNOTHERAPY OF EBOLA FEVER | 2015 |
|
RU2644202C2 |
| STRAIN OF EBOL VIRUS "ZAIR K-5" FOR CARRYING OUT MODEL EXPERIMENTS AND PREPARING DIAGNOSTIC AND VACCINE PREPARATIONS | 2001 |
|
RU2225439C2 |
| STRAIN OF HYBRID ANIMAL CELLS Mus musculus L - PRODUCER OF MONOCLONAL ANTIBODIES FOR EXPOSING VP40 PROTEIN OF EBOLA VIRUS, ZAIRE SUBTYPE (Mainga STRAIN) (VERSIONS), MONOCLONAL ANTIBODY PRODUCED BY SAID STRAIN (VERSIONS) AND SET FOR "SANDWICH" FORMAT IMMUNOENZYMOMETRIC TEST SYSTEM FOR EXPOSING VP40 PROTEIN OF EBOLA VIRUS, ZAIRE SUBTYPE (Mainga STRAIN) | 2008 |
|
RU2395577C1 |
| PREPARATION CONTAINING IMMUNOGLOBULIN AGAINST ABOL FEVER FROM HORSE BLOOD SERUM AND LIQUID ABOL IMMUNOGLOBULIN | 1996 |
|
RU2130318C1 |
| STRAIN OF EBOL VIRUS "ZAIR CH-5" FOR CARRYING OUT MODEL EXPERIMENTS AND PREPARING DIAGNOSTIC AND VACCINE PREPARATIONS | 2001 |
|
RU2225440C2 |
| METHOD OF PROPHYLAXIS OF VIRAL AEROGENIC INFECTIONS | 1995 |
|
RU2105565C1 |
| IMMUNOGEN PEPTIDES AND "EPIVAKEBOL" VACCINE AGAINST EBOLA FEVER WITH APPLICATION OF INDICATED PEPTIDES | 2017 |
|
RU2635998C1 |
| STRAIN OF HYBRID ANIMAL CELLS Mus museums L - PRODUCER OF MONOCLONAL ANTIBODIES FOR EXPOSING NUCLEOPROTEIN OF EBOLA VIRUS, ZAIRE SUBTYPE (Mainga STRAIN) (VERSIONS), MONOCLONAL ANTIBODY PRODUCED BY SAID STRAIN (VERSIONS) AND SET FOR "SANDWICH" FORMAT IMMUNOENZYMOMETRIC TEST SYSTEM FOR EXPOSING NUCLEOPROTEIN OF EBOLA VIRUS, ZAIRE SUBTYPE (Mainga STRAIN) | 2008 |
|
RU2395576C1 |
